Heart Disease Trial, Recruiting NCT07113223 Sponsor: Idoven 1903 S.L. Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07113223
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Group S – People with possible heart failure symptoms:

  • People aged 65 or older
  • People who are experiencing symptoms that may suggest heart failure, such as shortness of breath (during activity, at rest, when lying down, or waking at night struggling to breathe), tiredness, swollen ankles or legs, and/or a racing or irregular heartbeat
  • People who are able to understand the study requirements and agree to take part (either personally or through a legal representative)

Group R – People at risk of heart failure but without current symptoms:

  • People aged 65 or older
  • People who do not currently have any of the symptoms listed above
  • People who have at least one recognised heart failure risk factor, such as high blood pressure, atrial fibrillation, coronary heart disease, stroke, diabetes, obesity, past exposure to treatments that can affect the heart, or a personal or family history of a heart muscle condition
  • People who are having an ECG (a simple heart tracing test) for any reason at a primary care centre, or as part of a routine health check that includes an ECG
  • People who are able to understand the study requirements and agree to take part (either personally or through a legal representative)

Who may not be able to join:

  • People who are unwilling or unable to sign the consent form agreeing to take part
  • People who have already been diagnosed with heart failure
  • People for whom an ECG recording is not available or is of too poor a quality to be used in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +34917792640

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Idoven 1903 S.L.
Registry
ClinicalTrials.gov
Start date
23 July 2025
Est. completion
1 July 2026

Where this trial is recruiting

🇪🇸 Spain 🇸🇪 Sweden

Primary endpoints

Device performance in patients with suspected Heart Failure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov